首页> 外文期刊>Therapeutics and Clinical Risk Management >The role of inflammation in cardiovascular diseases: the predictive value of neutrophil–lymphocyte ratio as a marker in peripheral arterial disease
【24h】

The role of inflammation in cardiovascular diseases: the predictive value of neutrophil–lymphocyte ratio as a marker in peripheral arterial disease

机译:炎症在心血管疾病中的作用:中性粒细胞淋巴细胞比例作为外周动脉疾病标志物的预测值

获取原文
           

摘要

Peripheral arterial disease (PAD) is an important manifestation of atherosclerosis, with increasing prevalence worldwide. A growing body of evidence shows that the systemic inflammatory response is closely related to the development, progression, and prognosis of atherosclerosis. In the last decade, several studies have suggested the role of measured inflammatory biomarkers as predictors of severity and prognosis in PAD in an effort to stratify the risk of these patients, to improve treatment selection, and to predict the results after interventions. A simple inflammatory marker, more available than any other, is the neutrophil–lymphocyte ratio (NLR), which can be easily obtained in clinical practice, based on the absolute count of neutrophils and lymphocytes from the differential leukocytes count. Many researchers evaluated vigorously the NLR as a potential prognostic biomarker predicting pathological and survival outcomes in patients with atherosclerosis. In this work, we aim to present the role of NLR as a prognostic marker in patients with PAD through a thorough review of the literature.
机译:外周动脉疾病(PAD)是动脉粥样硬化的重要表现,普遍存在普遍存在。越来越多的证据表明,全身炎症反应与动脉粥样硬化的发展,进展和预后密切相关。在过去的十年中,一些研究表明,测量的炎症生物标志物作为垫中严重程度和预后的预测因子的作用,以便对这些患者的风险进行分层改善治疗选择,并预测干预后的结果。一种简单的炎症标记,比任何其他更具可用的是中性粒细胞淋巴细胞比(NLR),其可以在临床实践中,基于来自差分白细胞计数的中性粒细胞和淋巴细胞的绝对计数。许多研究人员剧烈评估NLR作为潜在的预后生物标志物预测动脉粥样硬化患者的病理和生存结果。在这项工作中,我们的目标是通过彻底审查文献来呈现NLR作为垫子患者的预后标志物的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号